1. Home
  2. BOLT vs PT Comparison

BOLT vs PT Comparison

Compare BOLT & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • PT
  • Stock Information
  • Founded
  • BOLT 2015
  • PT 2012
  • Country
  • BOLT United States
  • PT China
  • Employees
  • BOLT N/A
  • PT N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • PT Computer Software: Programming Data Processing
  • Sector
  • BOLT Health Care
  • PT Technology
  • Exchange
  • BOLT Nasdaq
  • PT Nasdaq
  • Market Cap
  • BOLT 16.8M
  • PT 15.2M
  • IPO Year
  • BOLT 2021
  • PT 2018
  • Fundamental
  • Price
  • BOLT $5.69
  • PT $0.90
  • Analyst Decision
  • BOLT Buy
  • PT
  • Analyst Count
  • BOLT 3
  • PT 0
  • Target Price
  • BOLT $50.00
  • PT N/A
  • AVG Volume (30 Days)
  • BOLT 23.5K
  • PT 15.7K
  • Earning Date
  • BOLT 08-12-2025
  • PT 07-07-2025
  • Dividend Yield
  • BOLT N/A
  • PT N/A
  • EPS Growth
  • BOLT N/A
  • PT N/A
  • EPS
  • BOLT N/A
  • PT N/A
  • Revenue
  • BOLT $3,638,000.00
  • PT $4,814,566.00
  • Revenue This Year
  • BOLT N/A
  • PT N/A
  • Revenue Next Year
  • BOLT $24.14
  • PT N/A
  • P/E Ratio
  • BOLT N/A
  • PT N/A
  • Revenue Growth
  • BOLT N/A
  • PT N/A
  • 52 Week Low
  • BOLT $5.20
  • PT $0.76
  • 52 Week High
  • BOLT $15.60
  • PT $1.15
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 42.69
  • PT 46.18
  • Support Level
  • BOLT $5.36
  • PT $0.82
  • Resistance Level
  • BOLT $6.07
  • PT $0.94
  • Average True Range (ATR)
  • BOLT 0.44
  • PT 0.06
  • MACD
  • BOLT -0.01
  • PT 0.00
  • Stochastic Oscillator
  • BOLT 25.58
  • PT 57.14

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

Share on Social Networks: